* Gohealth Inc GOCO.OQ GOCO.O is expected to show a rise in
quarterly revenue when it reports results on August 11.
* The Chicago, Illinois-based company is expected to report a
37.8% increase in revenue to $175.113 million from $127.06
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Gohealth Inc is for a
loss of 4 cents per share. For the same quarter last year, the
company reported a loss of 6 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Gohealth Inc is
$18, about 49.6% above its last closing price of $9.07.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.01 -0.01 -0.02 Missed -106
Dec. 31 2020 0.44 0.45 0.41 Missed -8.2
Sep. 30 2020 -0.02 -0.01 -0.65 Missed -4,297
.8
Jun. 30 2020 -0.04 -0.04 -0.06 Missed -50
This summary was machine generated August 9 at 23:15 GMT. All
figures in US dollars unless otherwise stated